● Recruiting

A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.

Condition: Pulmonary Arterial Hypertension PAH · Sponsor: ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.

PhasePhase 1/Phase 2

Planned participants120

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This is a Phase Ib/IIa clinical study of IMC-003 treatment in pulmonary arterial hypertension (PAH) patients receiving background therapy

This description comes directly from the study's public registry record.

Talk to the study team

Xiaojun Zhou · 021-58356573 · xiaojun.zhou@immunecarebio.com

Always discuss trial participation with your own doctor first.

Locations (29)

Xuanwu Hospital Capital Medical University	Beijing, Beijing Municipality, China	Not Yet Recruiting
The first hospital of Jilin University	Jilin City, Changchun, China	Recruiting
The first hospital of Jilin University	Jilin City, Changchun, China	Recruiting
Fujian Medical University Union Hospita	Fuzhou, Fujian, China	Not Yet Recruiting
Xiamen Hospital of T.C.M.	Xiamen, Fujian, China	Recruiting
Gansu Provincial Hospital	Lanzhou, Gansu, China	Recruiting
Guangdong Provincial People's Hospital	Guangzhou, Guangdong, China	Recruiting
Guangdong Provincial People's Hospital	Guangzhou, Guangdong, China	Recruiting
The Affiliated Hospital of Guizhou Medical University	Guiyang, Guizhou, China	Not Yet Recruiting
Fuwai Center China Cardiovascular Hospital	Zhengzhou, Henan, China	Not Yet Recruiting
The First Affiliated Hospital of Zhengzhou University	Zhengzhou, Henan, China	Recruiting
Wuhan Asia Heart Hospital	Wuhan, Hubei, China	Recruiting

+ 17 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07593027